Husain, Shajanie B.

HRN: 12-92-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2022
CEFUROXIME 500MG (TAB)
06/21/2022
06/23/2022
ORAL
500mg
BID
S/P Suction Curettage
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Duration  Further Investigation

Overall appropriateness: No  Further Investigation

Intervention



Type of Intervention done:

                    

           


Acceptance: